Peripheral blood abnormalities in patients with Covid 19 hospitalized in the pneumology department of Marrakesh University Hospital

Selma Abdala *, Salma Aitbatahar and Lamyae Amro

Faculty of Medicine and Pharmacy, Cadi Ayyad University, Department of Pneumology, ARRAZI Hospital, Mohamed VI University Hospital Center, Marrakesh, Morocco.
 
Research Article
World Journal of Advanced Research and Reviews, 2021, 09(01), 046-049
Article DOI: 10.30574/wjarr.2021.9.1.0497
 
Publication history: 
Received on 23 December 2020; revised on 29 December 2020; accepted on 01 January 2021
 
Abstract: 
In December 2019, Coronavirus 2019 due to SARS CoV 2 was first discovered in Wuhan, China and then rapidly spread to more than 200 countries. Until now, there is no specific vaccine and no effective treatment, so it is very important from a clinical point of view to predict the evolution of the disease. Thus, in order to further analyze the value of the clinical application of blood count parameters in the diagnosis or management of COVID-19 (Coronavirus disease 2019) patients. Peripheral blood abnormalities of 102 COVID-19 patients hospitalized in the pneumology department of CHU Mohamed VI in Marrakesh were analyzed retrospectively and compared to SARS CoV 2 negative patients.  Results: WBCs in the patient group were 8.32 ×109/L vs 5.85 ×109/L, p<0.001, an elevated neutrophil count (5.33 ×109/L vs 3.27 ×109/L, p<0. 001), a lower hemoglobin concentration (13.5 [10.6-16.37] g/dl vs 14.8 [13.5-15.6] g/dl, p<0.001), and a higher Neutrophils-to-lymphocytes ratio (2.63 vs 1.52, p<0.001). The severe cases had a higher white blood cell count (14,279 (±6,564) vs. 7,471 (±2,609) ×109/L, p<0.001), a much higher neutrophil count (12,547 (±6,698) vs. 4,468 (±1,882) ×109/L, p<0.001). Lymphopenia (0.851 (±0.406) vs. 2.138 (±1.103) ×109/L, p<0.001), NLR (14.74 vs. 2.08) and Platelets-to-lymphocytes ratio (145 vs. 117) were higher than the non-severe COVID-19 cases. Conclusion: In light of these data, we deduce that regular monitoring of blood counts should be involved to judge the progression and prognosis of COVID-19. 
 
Keywords: 
Peripheral blood; SARS CoV 2; Neutrophils; Lymphocytes
 
Full text article in PDF: 
Share this